Literature DB >> 17267190

Monolayers of porcine alveolar epithelial cells in primary culture as an in vitro model for drug absorption studies.

Anne Steimer1, Helmut Franke, Eleonore Haltner-Ukomado, Michael Laue, Carsten Ehrhardt, Claus-Michael Lehr.   

Abstract

Filter-grown monolayers of porcine alveolar epithelial cells (pAEpC) in primary culture have been characterized as an in vitro model for pulmonary absorption screening of xenobiotics, including substrates of efflux systems. Experimental conditions and a protocol for transport experiments were optimized using transepithelial electrical resistances (TEER) and permeability of marker compounds as acceptance criteria. Since new drugs often feature poor water solubility, monolayer integrity in the presence of a solubilizer (dimethyl sulfoxide) was tested. Transport studies were carried out with budesonide and triamcinolone acetonide, i.e., two drugs commonly administered to the lungs. Furthermore, expression of P-glycoprotein (P-gp) was assessed by immunofluorescence microscopy and transport studies employing the substrates rhodamine 123 and digoxin. Hydrocortisone-supplemented (0.5 microg/ml) small airway basal medium as transport buffer and a maximal solubilizer concentration of 1.5% dimethyl sulfoxide were found to provide suitable conditions for drug transport studies across pAEpC, as reflected, e.g., by a minimum TEER of 600 Omega cm(2). Permeation of marker compounds was reproducible throughout several cell preparations and proved the model successful in distinguishing between low- and high-permeable drugs. P-gp expression was confirmed by immunocytochemistry, even though transport studies revealed no polarity in transepithelial marker transport. In conclusion, our results demonstrate that filter-grown monolayers of pAEpC can be used to study drug transport across alveolar epithelial barrier and thus, may represent a suitable in vitro model for pulmonary drug absorption and delivery.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17267190     DOI: 10.1016/j.ejpb.2006.11.006

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  4 in total

1.  CFTR gene transfer with AAV improves early cystic fibrosis pig phenotypes.

Authors:  Benjamin Steines; David D Dickey; Jamie Bergen; Katherine Jda Excoffon; John R Weinstein; Xiaopeng Li; Ziying Yan; Mahmoud H Abou Alaiwa; Viral S Shah; Drake C Bouzek; Linda S Powers; Nicholas D Gansemer; Lynda S Ostedgaard; John F Engelhardt; David A Stoltz; Michael J Welsh; Patrick L Sinn; David V Schaffer; Joseph Zabner
Journal:  JCI Insight       Date:  2016-09-08

2.  Lung microdialysis study of levofloxacin in rats following intravenous infusion at steady state.

Authors:  Sandrine Marchand; Denis Frasca; Claire Dahyot-Fizelier; Céline Breheret; Olivier Mimoz; William Couet
Journal:  Antimicrob Agents Chemother       Date:  2008-06-30       Impact factor: 5.191

3.  Inflammatory response and barrier properties of a new alveolar type 1-like cell line (TT1).

Authors:  Ellen H J van den Bogaard; Lea Ann Dailey; Andrew J Thorley; Teresa D Tetley; Ben Forbes
Journal:  Pharm Res       Date:  2009-02-06       Impact factor: 4.200

4.  Nanoparticle translocation across mouse alveolar epithelial cell monolayers: species-specific mechanisms.

Authors:  Farnoosh Fazlollahi; Yong Ho Kim; Arnold Sipos; Sarah F Hamm-Alvarez; Zea Borok; Kwang-Jin Kim; Edward D Crandall
Journal:  Nanomedicine       Date:  2013-02-20       Impact factor: 5.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.